Immediate Impact
38 standout
Citing Papers
Dual blockade immunotherapy targeting PD-1/PD-L1 and CTLA-4 in lung cancer
2024 Standout
Epigenetics-targeted drugs: current paradigms and future challenges
2024 Standout
Works of Fengdan Wang being referenced
OA05.01 Efficacy/Safety of Entinostat (ENT) and Pembrolizumab (PEMBRO) in NSCLC Patients Previously Treated with Anti-PD-(L)1 Therapy
2018
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Fengdan Wang | 40 | 51 | 53 | 83 | 57 | 38 | 284 | |
| Iwona Kucybała | 73 | 62 | 33 | 38 | 22 | 21 | 299 | |
| Olga Růžičková | 14 | 92 | 27 | 66 | 51 | 24 | 300 | |
| Eckhart Fröhlich | 73 | 12 | 25 | 111 | 41 | 32 | 311 | |
| Kevin Yuqi Wang | 38 | 36 | 16 | 44 | 19 | 28 | 286 | |
| Prashant Kumar Verma | 19 | 10 | 37 | 53 | 40 | 42 | 324 | |
| Yining Wang | 34 | 21 | 21 | 89 | 40 | 36 | 217 | |
| Natalia Shor | 45 | 49 | 37 | 29 | 12 | 38 | 313 | |
| Marius Horger | 22 | 15 | 22 | 52 | 23 | 23 | 204 | |
| N. Faye | 91 | 45 | 17 | 85 | 33 | 23 | 269 | |
| B. Kurtz | 96 | 114 | 15 | 59 | 35 | 33 | 334 |
All Works
Login with ORCID to disown or claim papers
Loading papers...